早期NSCLC患者全胸腔镜肺叶切除术的临床应用研究进展

肺癌是世界上患病率和死亡率增长最快的恶性肿瘤,对人类的健康和生命有巨大威胁,其中非小细胞肺癌(NSCLC)的占比约为80％～85％,需引起高度重视.对早期NSCLC患者应积极实施根治术治疗以延缓病情发展,延长生存期.随着微创技术的发展和医疗设备的更新,全胸腔镜肺叶切除术作为一种微创术式已经在早期NSCLC患者临床治疗中...

Advances in clinical application of total thoracoscopic lobectomy in early NSCLC patients

Lung cancer is one of the malignant tumors with the fastest growth in morbidity and mortality in the world.It poses a great threat to human health and life.Among them,non-small cell lung cancer (NSCLC) accounts for about 80%~85%,which should be paid great attention to.Early NSCLC patients should be actively treated with radical operation to delay the development of the disease and prolong the survival time.With the development of minimally invasive technology and the renewal of medical equipment,total thoracoscopic lobectomy,as a minimally invasive procedure,has been widely used in the clinical treatment of early NSCLC patients,and its advantages over traditional open surgery have also been unanimously recognized by workers in this field.This paper first explores the anatomical basis of total thoracoscopic lobectomy,summarizes its indications,contrain dications and surgical procedures,and then focuses on its advantages and disadvantages in early NSCLC patients,with a view to providing a systematic reference for clinical treatment options.In the future,we should broaden the indications of the operation,improve and optimize the choice of incision,update the preoperative and intraoperative positioning methods,further explore the effect of the operation on the long-term survival rate,and pay attention to how to reduce the difficulty and cost of the operation.